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BRIEF DEFINITIVE REPORT

All-trans retinoic acid mediates enhanced
T reg cell growth, differentiation, and
gut homing in the face of high levels
of co-stimulation
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We demonstrate that all-trans retinoic acid (RA) induces FoxP3 adaptive T regulatory
cells (A-Tregs) to acquire a gut-homing phenotype (47 CC chemokine receptor 9)
and the capacity to home to the lamina propria of the small intestine. Under conditions
that favor the differentiation of A-Tregs (transforming growth factor–1 and interleukin 2)
in vitro, the inclusion of RA induces nearly all activated CD4 T cells to express FoxP3 and
greatly increases the accumulation of these cells. In the absence of RA, A-Treg differentiation is abruptly impaired by proficient antigen presenting cells or through direct
co-stimulation. In the presence of RA, A-Treg generation occurs even in the presence
of high levels of co-stimulation, with RA attenuating co-stimulation from interfering
from FoxP3 induction. The recognition that RA induces gut imprinting, together with our
finding that it enhances A-Treg conversion, differentiation, and expansion, indicates that
RA production in vivo may drive both the imprinting and A-Treg development in the face
of overt inflammation.

CORRESPONDENCE
Randolph J. Noelle:
Randolph.J.Noelle@
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T regulatory cells (T reg cells) function to temper the massive proinflammatory stimulus created
by commensal bacteria within the gut. Evidence
of their functional importance in suppressing
gut inflammation is observed by the fact that
their absence permits the onset of gut autoimmunity (1, 2). Therefore, manipulation of
T reg cell function within the gut provides an
attractive therapeutic approach in enforcing gut
tolerance during times when the balance is shifted
toward autoimmunity.
The ability of activated T cells to exit the
blood and enter different tissues of the body is
“imprinted” on them within the secondary lymphoid organs by DCs (3, 4). T cells homing to the
small intestine lamina propria express the integrin
␣4␤7, which binds mucosal addressin cell adhesion molecule–1 and CC chemokine receptor
(CCR) 9, whose ligand is secreted within the
lamina propria (5–8). A population of CD103⫹
DCs that primarily resides within the lamina
The online version of this article contains supplemental material.
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propria, Peyer’s patches, and mesenteric lymph
nodes are responsible for imprinting a gut-homing
capacity on T cells by an all-trans retinoic acid
(RA)–dependent mechanism (1, 9–11).
It has been shown that CD4⫹FoxP3− naive
T cells can be converted into CD4⫹FoxP3⫹
T reg cells (i.e., adaptive T reg cells [A-Tregs])
exhibiting the same suppressive and phenotypic
characteristics as thymically derived, natural T reg
cells (nTregs) both in vivo and in vitro (12–16).
This conversion is dependent on TGF-␤1 and
requires IL-2 in vitro (13, 17, 18). The use of
A-Tregs as a means of inducing tolerance has
been demonstrated in numerous settings, including inflammatory bowel disease and allotransplantation models (12, 15, 16, 19). Improving
the potency of A-Treg treatments is of great
clinical interest, and harnessing imprinting mechanisms to target A-Tregs to a specific organ is one
means to this end.
In this report, we use RA to generate a unique
population of A-Tregs in vitro that is able to
home in vivo to the small intestine lamina propria.
1765

Surprisingly, RA potently synergized with TGF-␤1 in driving
FoxP3 induction. In addition to increasing the frequency and
durability of these A-Tregs, RA also allowed FoxP3 expression to occur in the presence of high levels of co-stimulation,
levels that normally prevent FoxP3 induction. These experiments highlight the central importance of RA in serving two
roles: driving gut homing and permitting the development
of A-Tregs in the presence of overt inflammation. These data
implicate RA as a mediator of gut tolerance in vivo.

RESULTS AND DISCUSSION
RA synergizes with TGF-1 to generate A-Tregs
that home to the small intestine in vivo and express
suppressive activity
RA induces ␣4␤7 and CCR9 expression on CD4⫹ T cells
during in vitro activation (11). As A-Tregs can be generated from naive CD4⫹FoxP3⫺ cells in vitro during stimulation in the presence of TGF-␤1 and IL-2, we addressed
whether CD4⫹FoxP3⫺ T cells cultured with TGF-␤1, RA,

Figure 1. RA synergizes with TGF-␤1 in the generation of gut-homing A-Tregs in vitro. (A and B) FACS-sorted CD4⫹Foxp3⫺ cells from the Foxp3/
GFP reporter mouse were cultured under activating conditions with IL-2 and TGF-␤1 ⫾ 10 nM RA, and surface phenotype and Foxp3/GFP expression was
analyzed by flow cytometry after 5 d of culture. (A) Representative staining showing the percentage of Foxp3/GFP expression against CD25, CD62L, ␣4␤7,
CCR9, and CD103. (B) Representative FACS plot depicting Foxp3/GFP expression by CD4⫹ T cells. (C) Quantification of one representative experiment
showing the percentage of Foxp3/GFP⫹ cells among all CD4⫹ cells, with the selective RA receptor antagonist LE540 (1 M) included as indicated. Mean ⫾
SEM is shown. (D) Foxp3/GFP expression by CD4⫹ cells as a function of titrating concentrations of TGF-␤1 ⫾ RA. IL-2 concentrations were kept constant,
⫾RA, with TGF-␤1 (20 ng/ml, 10 ng/ml, 5 ng/ml, 1 ng/ml, and 0) titrated. (E) TGF-␤–mediated Foxp3/GFP expression as a result of titrating concentrations
of RA. Keeping IL-2 and TGF-␤1 constant, RA was titrated in serial dilutions (100 nM, 10 nM, 1 nM, 100 pM, 10 pM, 1 pM, and 0). All experiments shown
are representative of at least n = 3 independent experiments.
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and IL-2 under activating conditions would generate cells
with a CD4⫹FoxP3⫹␣4␤7⫹CCR9⫹ phenotype. We sorted
CD4⫹FoxP3⫺ cells from the FoxP3/GFP reporter mouse to
>99.9% purity, using this approach throughout the study
(20). After 5 d of activation by plate-bound ␣CD3/␣CD28
with TGF-␤1, IL-2, and RA, we observed the emergence of
CD4⫹FoxP3⫹␣4␤7⫹CCR9⫹ T cells (RA–T reg cells; Fig.
1 A). Concordant with conversion was the induction of CD25,
a marker for both T reg cells and activated T cells, and the
expression of CD103, which is induced by TGF-␤1 and
identifies an in vivo subset of effector/memory T reg cells,
which are more potent suppressors than T reg cells lacking
expression of this molecule (21–23). These data show that
a population bearing the phenotype of a gut-homing T reg cell
population was generated. Additionally, we observed a >90%
conversion rate of CD4⫹FoxP3⫺ to CD4⫹FoxP3⫹ T cells in
the presence of RA, compared with considerably less in its
absence (Fig. 1 B). Between experiments, we observed variable
conversion rates ranging between 15–50% in the culture
conditions of IL-2 and TGF-␤1, with the addition of RA
consistently increasing FoxP3 expression to 90% or greater.
This synergy between TGF-␤1 and RA in inducing FoxP3
expression could be blocked by the addition of the selective RA receptor antagonist LE540 (Fig. 1 C). RA was able
to enhance conversion throughout a titration of TGF-␤1,
although RA, by itself, did not induce conversion. The inability of RA to induce FoxP3 expression without the addition of exogenous TGF-␤1 indicates that conversion was
exclusively dependent on exogenous TGF-␤1 (Fig. 1 D).
Any endogenous TGF-␤ 1 potentially present within our
culture medium was unable to mediate this effect. When
RA was titrated against constant TGF-␤1 and IL-2, RA was
able to enhance TGF-␤1–dependent conversion even at subnanomolar concentrations (Fig. 1 E). For future experiments
within this study, unless otherwise indicated, we used 1 nM
RA in our cultures. This was done for two reasons: first, at
concentrations <1 nM, the percentage of T cells expressing
FoxP3 begins to decrease, and second, it has been observed
that RA has antiproliferative effects on T cells at high concentrations (30–100 nM RA suppresses T cell proliferation,
whereas doses <5 nM do not; unpublished data) (24). Results
similar to those shown in Fig. 1 (A–D) were observed using 1 nM RA. These data show that RA potently enhances
TGF-␤1–dependent FoxP3 induction.
The suppressive activity of RA–T reg cells was measured
relative to that of A-Tregs and freshly harvested nTregs in
an in vitro suppressor assay. The data show that RA–T reg
cells are potent suppressors of T effector cells in vitro (Fig. 2,
A and B). It is interesting to speculate that the RA–T reg
cells may even be more potent suppressors of T effector cell
proliferation, as indicated by their ability to suppress at T reg
cell/T effector cell ratios that nTregs and A-Tregs could
not suppress.
To examine the in vivo homing capacity of RA–T reg
cells, we performed an in vivo competitive homing experiment (3, 4). RA–T reg cells were generated in vitro from a
JEM VOL. 204, August 6, 2007

Ly5.2⫹FoxP3/GFP reporter mouse. Sorted CD4⫹CD25⫺
cells from a Ly5.2⫹ mouse that did not contain the FoxP3/
GFP knock-in allele were used to generate a population of
A-Tregs. As the A-Tregs were generated from mice lacking
the FoxP3/GFP allele, it was impossible to sort them to purity after inducing FoxP3 expression in vitro, and thus, the
A-Treg population used contained a substantial percentage
of FoxP3⫺ cells (unpublished data). However, this does not
diminish the utility of these cells in an in vivo competitive
homing experiment. RA–T reg cells and A-Tregs were
equally mixed and injected intravenously into recipient Ly5.1⫹
mice, and various organs were analyzed for donor cells after
18 h (Fig. 2 C). After at least 18 h, we did not observe reversion of CD4⫹FoxP3⫹ RA–T reg cells to a CD4⫹FoxP3⫺ phenotype in vivo (see Fig. 5 A). As expected from their phenotype,
the RA–T reg cells had the capacity to home to the small
intestine lamina propria and were in the minority compared
with A-Tregs in the blood and lung (Fig. 2 D). There was
also an accumulation of RA–T reg cells in the mesenteric
lymph nodes and the Peyer’s patches. Collectively, these data
show that functionally suppressive T reg cells with a guthoming phenotype can be generated from CD4⫹FoxP3⫺ T cells
in vitro, and this cell population has the capacity to home to
the small intestine in vivo.
Co-stimulation and A-T reg cell generation: RA allows DCs
to drive TGF-1–mediated FoxP3 induction
To investigate the capacity of different APC subsets to induce
A-Treg generation in vitro, peptide-pulsed splenic CD19⫹ B
cells and CD11c⫹ DCs were analyzed for their ability to drive
TGF-␤1–dependent FoxP3 induction in CD4⫹OTII⫹FoxP3⫺
cells harvested and purified by sorting from the OTII⫹FoxP3/
GFP mouse. A difference was observed between these two
APC subsets to mediate conversion: B cells repeatedly induced
conversion at rates between 40–60%, with DCs inducing
conversion at substantially lower rates of 0–14% (Fig. 3 A;
and Fig. S1, available at http://www.jem.org/cgi/content/
full/jem.20070719/DC1), consistent with a previous study (25).
The ability of B cells and DCs to mediate conversion was
further analyzed by titrating exogenous TGF-␤1, further substantiating the differential capacity of these APC subsets to mediate T reg cell generation (Fig. S1).
When the total number of CD4⫹ T cells per well after
culture was quantified, DCs generated far more CD4⫹ T cells
per well then B cells (Fig. 3 B). This was expected, given the
differing capacities of these APC subsets to activate T cells
through their differential co-stimulatory molecule expression,
with DCs far superior at activating CD4⫹ T cells than resting
B cells (26). We hypothesized that the capacity of APCs to
activate T cells through co-stimulatory molecule expression,
such as CD80/86, is inversely correlated with their ability to
support the generation of A-Tregs. By extension of this
hypothesis, the greater the absolute yield of daughter T cells
generated by an APC, the fewer the number of FoxP3expressing T cells. To test this hypothesis directly, we examined
the ability of CD80/86 knockout splenic DCs and B cells
1767

Figure 2. RA–T reg cells are suppressive in vitro and home to the small intestine in vivo. To examine the suppressive capacity of A-Tregs, RA–T
reg cells, and nTregs, Ly5.2⫹Foxp3/GFP⫹ A-Tregs and RA–T reg cells were generated in vitro and sorted to >99% purity, with Ly5.2⫹ nTregs freshly isolated
ex vivo from a Ly5.2⫹Foxp3/GFP reporter mouse. These T reg cell subsets were cultured with CFSE-labeled Ly5.1⫹CD4⫹ T effector cells at the indicated
ratios under activating conditions. Representative CFSE plots of the T effector cells are shown (A), with the percentage of dividing T effector cells quantified (B).
(C and D) Representative in vivo competitive homing assay. Naive CD4⫹Foxp3⫺ cells were sorted from an Ly5.2⫹Foxp3/GFP reporter mouse and activated
for 5 d in the presence of TGF-␤1, IL-2, and RA to generate RA–T reg cells expressing Foxp3/GFP. Naive CD4⫹CD25⫺ cells were sorted from an Ly5.2⫹
mouse and cultured under the same conditions, minus the RA, to generate A-Tregs lacking the Foxp3/GFP allele. These two cell populations were mixed
and injected into recipient mice. (C) Organs were harvested after 18 h and stained for donor Ly5.2⫹CD4⫹ T cells, and the ratio of GFP⫹/⫺ cells within the
donor population was analyzed, with a representative mouse shown. Numbers show the percentage of transfered cells that are FoxP3/GFP⫺ and FoxP3/GFP⫹.
(D) The HI (ration of [GFP⫹]tissue/[GFP⫺]tissue to [GFP⫹]input/[GFP⫺]input) was calculated, with bar graphs showing mean ⫾ SEM of one representative
experiment using three recipient mice. Peripheral lymph node (pLN): HI ⫽ 0.96 (SEM ⫽ 0.13); spleen: HI ⫽ 0.96 (SEM ⫽ 0.08); blood: HI ⫽ 0.56 (SEM ⫽
0.05); lung: HI ⫽ 0.39 (SEM ⫽ 0.02); mesenteric lymph node (mLN): HI ⫽ 1.86 (SEM ⫽ 0.1); Peyer’s patches (PP): HI ⫽ 3.46 (SEM ⫽ 0.33); and lamina propria (LP): HI ⫽ 12.27 (SEM ⫽ 0.77). All experiments are representative of at least two independent experiments. *, P ⬍ 0.05; **, P ⬍ 0.01; and ***, P ⬍ 0.001
compared with HI ⫽ 1 (dotted line).

to mediate both conversion and T cell expansion. The CD80/86
knockout DCs were able to induce TGF-␤1–dependent
FoxP3 expression in CD4⫹ T cells at a substantially increased rate in comparison with WT DCs (81.33% [SD = 2.31]
compared with 7.9% [SD = 1.14]; Fig. 3 A). There was no
1768

change in the ability of WT B cells versus CD80/86 knockout B cells to mediate conversion (63% [SD = 7.81] and
67.66% [SD = 5.03], respectively), which is expected
because quiescent B cells express very low basal levels of
CD80/86 (26).
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Figure 3. DC expression of CD80/86 co-stimulatory molecules prevents Foxp3 induction by T cells, with exogenous RA overcoming this
inhibition and allowing T reg cell generation. Sorted CD4⫹OTII⫹Foxp3⫺ T cells from the OTII⫹Foxp3/GFP reporter mouse (100,000 T cells/well) were
cultured with either purified WT or CD80/86 knockout CD19⫹ B cells or CD11c⫹ DCs (100,000 APCs/well) pulsed with ISQ peptide, or under activating
conditions. Media was supplemented with 100 U IL-2, ⫾20 ng/ml TGF-␤1, ⫾1 nM RA, ⫾10 g/ml ␣CD154 (unless otherwise indicated) for 5 d. (A) WT or
CD80/86 knockout splenic B cells or DCs plus T cells were cultured under the depicted culture conditions, and the percentage of CD4⫹ T cells expressing
Foxp3/GFP was measured. (B) Same experimental conditions as in A, except with absolute CD4⫹ T cells per well counted, with white bars representing
CD4⫹Foxp3⫺ cells and green bars representing CD4⫹Foxp3⫹ cells. (C) Freshly harvested B cells (quiescent B cells) or 48-h preactivated B cells with the
indicated stimulus were co-cultured with T cells, and the percentage of CD4⫹ cells expressing Foxp3/GFP was measured after 5 d. (D) CD4⫹ T cells were
activated using 10 g/ml of plate-bound ␣CD3 and titrating concentrations of ␣CD28, with media supplemented with IL-2 and TGF-␤1 ⫾10 nM RA as
indicated; Foxp3/GFP expression was plotted as a function of plate-bound ␣CD28 concentration. Mean ⫾ SEM is depicted in A, B, and D.

The in vitro and in vivo activation of both B cells and DCs
through CD40 engagement by its ligand, CD154, increases
the expression of CD80/86 by these APCs. The inclusion of
blocking ␣CD154 antibody to our co-cultures enabled DCs to
have an increased ability to mediate conversion (7.94% [SD =
1.14] compared with 15.26% [SD = 0.55] with ␣CD154;
Fig. 3 A). Similar results were observed using CD40 knockout DCs (unpublished data). Interestingly, ␣CD154 antibody
appeared to decrease B cell–mediated conversion, possibly
implying a requirement for very low levels of co-stimulation
in this co-culture system (63% [SD = 7.81] compared with
39.33% [SD = 4.5] with ␣CD154).
JEM VOL. 204, August 6, 2007

We next addressed whether B cell activation and the acquisition of heightened co-stimulatory molecule expression
impaired the ability to induce conversion. When B cells were
preactivated for 48 h by either LPS or agonistic-␣CD40 supplemented with IL-4 and then used as APCs, B cell–mediated
conversion was impaired (Fig. 3 C).
When CD4⫹ T cells were activated using WT or CD80/86
knockout DCs in the presence of exogenous IL-2, considerably more T cells per well were generated by WT
DCs in comparison with CD80/86 knockout DCs (19.64 ⫻
104 cells [SD = 2.42 ⫻ 104] compared with 9.13 ⫻ 104 cells
[SD = 2.48 ⫻ 104]; Fig. 3 B). The addition of RA or TGF-␤1
1769

Figure 4. RA enhances Foxp3 expression without impeding T cell
activation and proliferation. Purified CFSE-labeled CD4⫹CD25⫺ T cells
from a WT B6 mouse were cultured with IL-2, TGF-␤1, and 1 nM RA, as
indicated, under activating conditions for 4 d, after which CD62L and
Foxp3 expression was measured. (A) CFSE dye dilution versus CD62L
expression is shown, with T cells cultured with IL-2 or IL-2 plus 1 nM RA
under different activating conditions. The percentage of T cells within
1770

or both did not affect this observed difference (Fig. 3 B).
Upon the addition of TGF-␤1 to these cultures, the decrease
of T cell numbers between WT and CD80/86 knockout
DCs inversely correlated with a substantial increase in the
number of FoxP3-expressing T cells in the CD80/86 knockout group versus the WT group (6.35 ⫻ 104 cells [SD =
0.15 ⫻ 104] compared with 1.33 ⫻ 104 cells [SD = 0.25 ⫻
104]; Fig. 3 B).
The addition of ␣CD154 did not lead to a considerable
change in T cell numbers generated by DCs with the addition of exogenous IL-2 (19.64 ⫻ 104 [SD = 2.42 ⫻ 104] compared with 11.13 ⫻ 104 [SD = 7.75 ⫻ 104] with ␣CD154;
Fig. 3 B). No difference in T cell number was again observed
with the further addition of RA or TGF-␤1, or both. Additionally, there was no considerable increase in the numbers of
FoxP3-expressing cells because of the inclusion of ␣CD154
to our DC co-cultures supplemented with TGF-␤1 (1.33 ⫻
104 [SD ⫽ 0.25 ⫻ 104] compared with 1.56 ⫻ 104 [SD = 0.36 ⫻
104]; Fig. 3 B). Despite the enhanced conversion imparted
by ␣CD154 in our DC/T cell co-cultures in Fig. 3 A, this
result was not entirely unexpected. First, even with a CD154/
CD40 blockade, DCs will still express levels of CD80/86 that
are sufficient in expanding T cells. Second, the increase in DCmediated conversion caused by ␣CD154 may not be enough
to net an absolute increase in T reg cell numbers in this experimental system.
B cells, CD80/86 knockout B cells, and B cells cultured
with ␣CD154 all generated similar total numbers of T cells in
all culture conditions. This was expected and is likely caused
by the low levels of co-stimulatory molecule expression on
the surface of resting B cells (26). Collectively, these data support our hypothesis that under conditions favoring conversion, the greater the absolute yield of T cells generated by an
APC and the fewer the number of T cells expressing FoxP3.
Further substantiating this is our finding that increasing levels
of plate-bound co-stimulation inversely correlates with the
absolute number of A-Tregs generated (Fig. S2, available at
http://www.jem.org/cgi/content/full/jem.20070719/DC1).
To directly implicate CD28 as a major mediator affecting
FoxP3 induction, we varied the magnitude of ␣CD28 costimulation in an in vitro assay in which plate-bound agonistic
␣CD28 was titrated against saturating concentrations of platebound ␣CD3. It was observed that ␣CD28 concentration had
an inverse relationship with A-Treg generation, with optimal
conversion occurring at ␣CD28 concentrations of 1 g/ml
and below. At saturating concentrations (10 g/ml ␣CD28),
no conversion was observed (Fig. 3 D). Collectively, these data
show that high levels of CD80/86 co-stimulation, such as those
observed on splenic CD11c⫹ DCs, impairs TGF-␤1–driven
FoxP3 induction and A-Treg generation while inducing
each quadrant is depicted. (B) Histograms depicting CFSE dye dilution
profiles of the data shown in A (IL-2, blue; IL-2 with 1 nM RA, red).
(C) CFSE dye dilution versus Foxp3 expression is shown with the indicated
activating and culture conditions, with the percentage of cells in each quadrant shown. Representative experiments of at least n ⫽ 3 mice are shown.
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maximal expansion of T cells. In the context of minimal to
no CD80/86 co-stimulation, such as levels present on resting
B cells and CD80/86 knockout DCs, little to no expansion
occurs, with TGF-␤1–dependent FoxP3 expression and T reg
cell generation the result.
The addition of RA to our assays greatly enhanced both
the percentage and total numbers of T cells expressing FoxP3
in a TGF-␤1–dependent manner (Fig. 3, A and B; Fig. S1;
and Fig. S2). Notably, the addition of RA to our DC/T cell
co-cultures increased the percentage of T cells expressing
FoxP3 from 7.94% (SD = 1.14) to 72% (SD = 2; Fig. 3 A).
Additionally, the combination of RA with TGF-␤1 resulted
in a net increase in the numbers of FoxP3-expressing cells in
all DC cultures in comparison with TGF-␤1 alone (WT
DCs: from 1.33 ⫻ 104 [SD = 0.25 ⫻ 104] to 9.96 ⫻ 104 [SD ⫽
0.62 ⫻ 104]; CD80/86 knockout DCs: from 6.35 ⫻ 104
[SD = 0.15 ⫻ 104] to 8.7 ⫻ 104 [SD = 0.19 ⫻ 104]; DCs with
␣CD154: from 1.56 ⫻ 104 [SD = 0.36 ⫻ 104] to 9.9 ⫻ 104
[SD = 0.19 ⫻ 104]; Fig. 3 B and Fig. S1). Furthermore, RA
reversed co-stimulation from suppressing, in dose-dependent
manner, the net yield of FoxP3⫹ T cells, as concentrations of
plate-bound ␣CD28 now positively correlate with FoxP3⫹
T cell numbers (Fig. S2). Across all concentrations of platebound ␣CD28, as well as in the presence of only a TCR signal with no ␣CD28, RA greatly enhanced the percentage
of T cells expressing FoxP3 (Fig. 3 D). In this experiment,
co-stimulation still affected FoxP3 induction in a dosedependent manner, albeit to a substantially attenuated degree,
as a result of the inclusion of RA. This suggests that RA lowers an as yet undefined threshold within the T cell, with this
threshold determining whether the T cell can convert into a
T reg cell. Thus, the presence of RA during antigen presentation allows TGF-␤1–dependent FoxP3 induction to occur
by T cells, even in the face of overt CD80/86 co-stimulation
afforded by the DC.
RA enhances FoxP3 expression without impeding T cell
activation and proliferation
The observation that RA–T reg cells can be induced in the
presence of high levels of co-stimulation led us the question
whether this occurs by RA functioning to interrupt T cell
activation and proliferation. To visualize this, CFSE-labeled
CD4⫹CD25⫺ cells were stimulated in the presence and absence of 1 nM RA, with T cell activation determined by
CD62L expression and proliferation by CFSE dye dilution.
The data shows that 1 nM RA does not suppress T cell activation, as indicated by CD62L expression. Instead, RA
appears to enhance T cell activation, as indicated by the
decreased expression of CD62L across the three levels of
activating conditions tested (Fig. 4 A). Additionally, when
CFSE histograms between different culture conditions are
overlaid, equivalent profiles indicate that the addition of
RA does not impede T cell proliferation (Fig. 4 B). The addition of TGF-␤1 to these cultures generated FoxP3⫹ cells
at expected frequencies throughout all peaks of cell division,
with no impediment in cell division observed because of
JEM VOL. 204, August 6, 2007

the presence of RA (Fig. 4 C). Importantly, RA enhances
TGF-␤1–mediated FoxP3 expression in the absence of any
␣CD28 signal and just the presence of ␣CD3 (Fig. 4 C
and Fig. 3 D). Collectively, these data show that RA enhances
FoxP3 induction and attenuates co-stimulation from interfering with T reg cell generation through a mechanism independent of dampening T cell activation and proliferation.
Furthermore, co-stimulation is not needed for RA to enhance
FoxP3 induction.
RA–T reg cells are refractory to reversion in vivo
RA is known to induce differentiation in a variety of primary
and tumor cell types. As such, we addressed whether RA–T

Figure 5. RA–T reg cells are refractory to reversion in vivo. The
ability of RA–T reg cells and A-Tregs to revert in vivo was analyzed by
transferring 1.5–2 ⫻ 106 FACS-sorted congenically marked OTII⫹ RA–T reg
cells or A-Tregs generated from a Ly5.2⫹OTII⫹Foxp3/GFP mice into Ly5.1⫹
hosts, who were either left untouched or intraperitoneally injected on the
same day with either CFA or 1 mg OVA/CFA, as indicated. Donor RA–T reg
cells or A-Tregs within the spleen were analyzed for Foxp3 expression on
day 5 by staining for CD4⫹Ly5.2⫹ cells. RA–T reg cells are red, whereas
A-Tregs are black (A). Horizontal lines represent the means. To examine
relative donor T cell expansion 5 d after transfer, the percentage of donor
OTII⫹ cells within the recipient splenic CD4⫹ compartment is shown in
a box and whisker plot depicting the median, 25th, and 75th percentiles
and range of values (B). Data are pooled from n ⫽ 3 independent
experiments. ***, P < 0.001.
1771

reg cells were more committed to the T reg cell lineage and
less prone to revert to FoxP3− T cells then A-Tregs in vivo.
To examine the propensity of A-Tregs and RA–T reg cells
to revert under different in vivo conditions, these cells were
generated from Ly5.2⫹OTII⫹FoxP3/GFP reporter mice, sorted
to >99.9% FoxP3⫹, and transferred into Ly5.1⫹ recipients.
Hosts were either unmanipulated, or immunized with OVA/
CFA or PBS/CFA (Fig. 5 A). After 5 d, the transferred cells
were analyzed for FoxP3 expression. Very few (9%) RA–T
reg cells lost FoxP3 expression in both the unmanipulated or
CFA only mice, indicating stability in RA–T reg cell differentiation even in the presence of inflammation. Surprisingly,
a much larger percentage of A-Tregs lost FoxP3 expression
in both unmanipulated and CFA only treated mice (40%)
when compared with RA–T reg cells in similarly treated
mice (9%). When injected with OVA/CFA, the frequency of
FoxP3⫹ cells was reduced in both RA–T reg cell and A-Treg
populations at similar rates. As expected, these CD4⫹OTII⫹
cells expanded within the recipients upon antigen injection
(Fig. 5 B). In conclusion, RA–T reg cells were more refractory
to reversion then A-Tregs under unmanipulated and inflammatory conditions, yet antigen encounter with inflammation
drove partial reversion in both groups.
The data presented in this report shows that RA is a
powerful inducer of FoxP3 expression and enhances commitment to the T reg cell lineage. The inclusion of RA during
the generation of A-Tregs (a) imprints a gut-homing capacity,
(b) allows FoxP3 induction in the presence of high levels
of co-stimulation by attenuating the inhibitory impact of costimulation on FoxP3 induction, (c) increases the frequency
and total numbers of FoxP3⫹ T cells, and (d) induces T reg
cells that are more refractory to reversion in vivo. Additionally, we implicate CD80/86 expression by APCs as a major
mediator of A-Treg generation, as graded ligation of CD28
on the CD4⫹ T cell surface has an inverse relationship with
the capacity of that T cell to express FoxP3 in a TGF-␤1–
dependent manner. Collectively, these data underscore the
potentially overwhelming impact of DCs producing RA
within the gut on the fate of activated T cells. Despite their
propensity to mediate A-Treg generation, it is unlikely that
B cells contribute to dual gut imprinting and A-Treg generation. Unlike gut-derived DCs, B cells harvested from
the spleen, Peyer’s patches, or mesenteric lymph nodes do
not imprint a gut-homing phenotype on CD4⫹ T cells (unpublished data). Because of this, B cells are not likely to secrete
RA in vivo.
The implications of these data are important. First, Powrie
et al. and Agace et al. jointly described CD103⫹CD11c⫹
DCs present within the mesenteric lymph nodes, Peyer’s
Patches, and small and large bowel lamina propria as composing
the DC subset responsible for mediating gut imprinting of
T cells through CCR9 and ␣4␤7 induction. Second, these
CD103⫹ DCs likely imprint through an RA-dependent
mechanism, although this has not yet been directly shown
(9, 10). Therefore, our data suggest a new role for RA in
mediating not only gut imprinting but also in driving gut
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tolerance through RA–T reg cell induction. Finally, with the
use of A-Tregs in cellular adoptive therapies on the horizon,
the use of RA in vitro to facilitate the production of fully
committed, gut-homing A-Tregs is an attractive technology to
meet the needs for high numbers of these cells in the therapeutic
treatment of autoimmune disorders such as inflammatory
bowel disease.
MATERIALS AND METHODS
Mice and immunizations. This study was approved by the Institutional
Animal Care and Use Committee of Dartmouth College. C57BL/6 and
C57BL/6 CD45.1 (Ly5.2⫹) mice were purchased from the National Cancer Institute. C56BL/6 CD40⫺/⫺ mice were purchased from the Jackson
Laboratory. FoxP3/GFP reporter mice were previously described and were
provided by A. Rudensky (University of Washington School of Medicine,
Seattle, WA) (20). FoxP3/GFP mice were bred onto OTII TCR-Tg mice
purchased from the Jackson Laboratory. CD80/86 double knockout mice
on the C57BL/6 background were a gift from E. Usherwood (Dartmouth
Medical School, Lebanon, NH). All animals were maintained in a pathogenfree facility at Dartmouth Medical School. For immunizations, OVA
(Sigma-Aldrich) resuspended in PBS or PBS alone was emulsified in CFA
(Sigma-Aldrich) at a 1:1 ratio and intraperitoneally injected in a volume
of 200 l.
Cell preparation. B cells and DCs were harvested from the spleens, and
CD4⫹FoxP3⫺ cells were isolated from spleens and peripheral and mesenteric lymph nodes. For B cell and T cells, single-cell suspensions were generated by crushing organs by sterile slides and were purified by positive
selection using either ␣CD4- or ␣CD19-labeled magnetic beads (Miltenyi
Biotec). T cells were further purified by FACS sorting (FACSAria; BD
Biosciences) of the CD4FoxP3/GFP⫺ fraction, with purity always >99.9%.
For CD11c⫹ selection, spleens were harvested and incubated at 37°C
in RPMI 1640 with 50 g/ml DNase I (Sigma-Aldrich) and 250 g/ml
Liberase (Roche) for 30 min, pushed through a 100-M filter to create a
single-cell suspension, and purified using ␣CD11c magnetic beads (Miltenyi
Biotec). Cell preparations were always >98% in purity. For small intestine
lamina propria lymphocyte preparations, intestines were removed, and
Peyer’s Patches were excised and used for further analysis. The intestines
were washed with cold PBS, split open, and cut into 1-cm pieces. After
30 min of incubation in unsupplemented RPMI to release the intestinal
epithelial lymphocytes, intestines were vortexed, filtered using a 100-M
filter, and extensively washed. Intestines were digested for 2 h using 50 g/ml
DNase I and 250 g/ml Liberase, after which they were pushed through a
100-M filter. The cellular suspension was centrifuged and suspended in
40% Percoll, and overlaid on 60% Percoll. The Percoll gradient was spun at
400 g at room temperature for 25 min with no brake, with the buffy (lymphocyte) coat removed for further use. As indicated in the figures, APCs
were pulsed with ISQ peptide at 10 g/ml for 1 h in cRPMI in sixwell
plates at a concentration of 10 ⫻ 106 cells/ml, and were washed, counted,
and used.
Cell culture/reagents. Cells were cultured in RPMI 1640 media supplemented with 10% FBS (Atlanta Biologicals), Hepes, 50 M ␤-ME, and
penicillin/streptomycin/l-glutamine. LPS was purchased from Sigma-Aldrich.
␣CD40 (clone FGK-45), ␣CD154 (clone MR1), ␣CD28 (clone PV-1), and
␣CD3 (clone 2C11) were purchased from ISC BioExpress. LE540 was
purchased from Wako Chemicals. For 96-well plate cultures, 200,000 cells
in APC/T cell co-cultures (1:1 ratio) in round-bottom plates or 100,000
T cells in flat-bottom plates were cultured in 200 l of media. In each experiment, triplicate wells of each experimental condition were set up. For
the bulk RA–T reg cell and A-Treg cultures in Fig. 2 and Fig. 5, 24-well
flat-well plates were used with 100,000 CD4⫹FoxP3⫺ cells/well in 1 ml of
THE GENERATION OF GUT-HOMING ADAPTIVE T REGULATORY CELLS | Benson et al.

BRIEF DEFINITIVE REPORT

media. For all cultures, unless indicated otherwise in the figures, T cells were
activated with 1 g/ml ␣CD28 and 10 g/ml ␣CD3 plate-bound antibody in
the presence of 20 ng/ml hTGF-␤1 (PeproTech), 100 U hIL-2 (PeproTech),
and RA (Sigma-Aldrich). For the in vitro suppressor assay, 50,000 CFSE-labeled
CD4⫹ T cells were co-cultured with 100,000 irradiated T cell–depleted
splenocytes, 5 g/ml ␣CD3, and the numbers of T reg cells indicated in the
figures for 4 d, as previously described (27, 28). For Fig. 3 and Fig. S2, cells
were counted by Guava according to instructions provided by the manufacturer (Guava Technologies)
Flow cytometry. The following antibodies were used: CD11c (clone
N418), CD25 (clone PC61), and CD62L (clone MEL-14; all obtained from
BioLegend); B220 (clone 6B2), CD4 (clone L3T4), and ␣4␤7 (clone DATK32;
all obtained from BD Biosciences); CCR9 (clone 242503; obtained from
R&D Systems); and CD103 (clone 2E7) and the FoxP3 intracellular staining
kit (obtained from eBioscience). For CFSE dye dilution, cells were labeled
with 5 M CFSE (Invitrogen). Flow cytometric analysis was performed on
a refurbished machine (FACScan; Becton Dickinson) running CellQuest
software (BD Biosciences), and data analysis was performed using FlowJo
software (TreeStar, Inc.).
Homing assay. Competitive homing experiments of RA–T reg cells and
A-Tregs were performed as previously described, with modifications (3). In
brief, 10 × 106 RA–T reg cells generated from sorted CD4⫹FoxP3⫺ cells
purified from a Ly5.2⫹FoxP3/GFP reporter mouse were mixed with an
approximately equal number of A-Tregs generated from FACS-sorted
CD4⫹CD25⫺ cells harvested from a Ly5.2⫹ mouse (determined to be ⵑ20%
FoxP3⫹, as gauged by intracellular FoxP3 staining) and intravenously injected into Ly5.1⫹ C57BL/6 mice. An aliquot was saved to determine the
input ratio: IR = (GFP⫹)input/(GFP⫺)input). The homing index (HI) was calculated as the ratio of (GFP⫹)tissue/(GFP⫺)tissue to IR. Homing indices were
tested versus HI = 1 using a one-sample Wilcoxon signed-rank test. Significance was set at P < 0.05.
Online supplemental material. Fig. S1 shows that DCs, with the addition
of exogenous RA, can induce FoxP3 expression in T cells in a TGF-␤1–
dependent manner and over a dose titration of TGF-␤1. Fig. S2 shows that
the addition of exogenous RA to TGF-␤1 and IL-2 induces a net increase in
the total number of T reg cells generated under various levels of plate-bound
co-stimulation. Online supplemental material is available at http://www
.jem.org/cgi/content/full/jem.20070719/DC1.
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